| Primary |
| Bipolar Disorder |
21.3% |
| Depression |
15.9% |
| Schizophrenia |
14.5% |
| Bipolar I Disorder |
11.9% |
| Psychotic Disorder |
7.5% |
| Anxiety |
4.0% |
| Schizoaffective Disorder |
3.5% |
| Childhood Psychosis |
3.0% |
| Insomnia |
2.3% |
| Schizophrenia, Paranoid Type |
2.3% |
| Abnormal Behaviour |
2.1% |
| Hypomania |
1.9% |
| Mania |
1.6% |
| Sleep Disorder |
1.4% |
| Agitation |
1.2% |
| Alcoholism |
1.2% |
| Hypertension |
1.2% |
| Major Depression |
1.2% |
| Gastritis |
0.9% |
| Hiv Infection |
0.9% |
|
| Weight Increased |
11.0% |
| Suicide Attempt |
9.8% |
| Toxicity To Various Agents |
9.8% |
| Mania |
7.3% |
| Pulmonary Embolism |
7.3% |
| Intestinal Obstruction |
6.1% |
| Urinary Retention |
6.1% |
| Treatment Noncompliance |
4.9% |
| Cerebrovascular Accident |
3.7% |
| Completed Suicide |
3.7% |
| Pneumonia Aspiration |
3.7% |
| Tachycardia |
3.7% |
| Thrombocytopenia |
3.7% |
| Tonsillitis |
3.7% |
| Vomiting |
3.7% |
| Diabetes Mellitus |
2.4% |
| Exposure During Pregnancy |
2.4% |
| Grand Mal Convulsion |
2.4% |
| Off Label Use |
2.4% |
| Pancreatitis |
2.4% |
|
| Secondary |
| Bipolar Disorder |
23.5% |
| Depression |
19.5% |
| Hypomania |
10.2% |
| Schizophrenia |
8.7% |
| Psychotic Disorder |
6.8% |
| Bipolar I Disorder |
6.0% |
| Childhood Psychosis |
3.4% |
| Anxiety |
2.7% |
| Schizophrenia, Paranoid Type |
2.6% |
| Sleep Disorder |
2.6% |
| Schizoaffective Disorder |
2.3% |
| Dissociative Identity Disorder |
2.1% |
| Alcoholism |
1.7% |
| Product Used For Unknown Indication |
1.4% |
| Type 2 Diabetes Mellitus |
1.4% |
| Insomnia |
1.3% |
| Migraine |
1.3% |
| Abnormal Behaviour |
1.1% |
| Major Depression |
0.9% |
| Agitation |
0.6% |
|
| Weight Increased |
13.8% |
| Suicide Attempt |
11.7% |
| Pancreatitis Acute |
9.6% |
| Cerebrovascular Accident |
7.4% |
| Pneumonia Aspiration |
7.4% |
| Toxicity To Various Agents |
7.4% |
| Neuroleptic Malignant Syndrome |
5.3% |
| Mania |
4.3% |
| Eyelid Oedema |
3.2% |
| Gamma-glutamyltransferase Increased |
3.2% |
| Haematochezia |
3.2% |
| Phlebitis |
3.2% |
| Sepsis |
3.2% |
| Sleep Disorder Due To General Medical Condition, Insomnia Type |
3.2% |
| Urinary Retention |
3.2% |
| Exposure During Pregnancy |
2.1% |
| Neutropenia |
2.1% |
| Pancytopenia |
2.1% |
| Rash Erythematous |
2.1% |
| Shock |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
29.5% |
| Personality Disorder |
20.5% |
| Toxicity To Various Agents |
6.8% |
| Bipolar Disorder |
4.5% |
| Chronic Obstructive Pulmonary Disease |
4.5% |
| Convulsion |
4.5% |
| Convulsions |
4.5% |
| Parkinson's Disease |
4.5% |
| Prophylaxis Against Hiv Infection |
4.5% |
| Coronary Artery Disease |
2.3% |
| Crohn's Disease |
2.3% |
| Grand Mal Convulsion |
2.3% |
| Grand Mal Epilepsy |
2.3% |
| Hypertension |
2.3% |
| Orthostatic Hypotension |
2.3% |
| Prostate Cancer |
2.3% |
|
| Mixed Liver Injury |
21.4% |
| Septic Shock |
14.3% |
| White Blood Cell Count Increased |
14.3% |
| Haemorrhagic Stroke |
7.1% |
| Hallucination |
7.1% |
| Polyneuropathy |
7.1% |
| Psychotic Disorder |
7.1% |
| Respiratory Rate Decreased |
7.1% |
| Tooth Loss |
7.1% |
| Toxicity To Various Agents |
7.1% |
|
| Interacting |
| Bronchitis |
21.4% |
| Nasopharyngitis |
21.4% |
| Psychotic Disorder |
21.4% |
| Depression |
14.3% |
| Hiv Infection |
7.1% |
| Mood Altered |
7.1% |
| Schizophrenia |
4.8% |
| Colitis Ulcerative |
2.4% |
|
| Syncope |
50.0% |
| Dyskinesia |
16.7% |
| Grand Mal Convulsion |
16.7% |
| Vitamin B12 Decreased |
16.7% |
|
